Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

June 26, 2025

Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments

June 26, 2025

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

June 25, 2025

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

European Pharmacopoeia Goes Digital

June 25, 2025

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Looking Beyond mRNA-based COVID-19 Vaccines to Innovative Therapeutics

June 24, 2025

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.

Six Biosimilars Part of EMA’s Authorization Recommendations in June

June 23, 2025

A total of 13 drugs were granted recommendation for market authorization at EMA’s CHMP June 2025 meeting.

Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model

June 19, 2025

Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.

BASF Opens GMP Manufacturing Facility in Michigan

June 19, 2025

The new facility offers cleanroom packaging and high-sensitivity analytical testing.

FDA Voucher Program Provides Shorter Drug Application Review Time

June 18, 2025

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.

BIO 2025: Pulmonary Drug Delivery

June 16, 2025

PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out what’s new in pulmonary drug delivery.